Objetivo
Causes explaining the epidemic of IgE-associated (allergic) diseases are unclear. MeDALL (Mechanisms of the Development of Allergy) aims at generating novel knowledge on mechanisms of allergy initiation, in particular in childhood. To understand how a complex network of genetic and environmental factors leads to complex allergic phenotypes, a novel stepwise, large and integrative translational approach is needed. MeDALL includes experts in allergy, epidemiology, genetics, immunology, biology, animal models, biochemistry and systems biology combining strengths of ongoing EU projects. Classical phenotypes (expert-based) and novel phenotypes of allergy (hypothesis-free statistical modelling) are compared. Population-based data are collected from a cross-sectional study (Karelia) and existing birth-cohorts followed using a common protocol. IgE to foods and inhalants are tested using component-resolved diagnosis across Europe in populations. Biomarker profiles (“fingerprints”) are extensively assessed using epigenetics, targeted proteomics and unbiased transcriptomics in a subsample of the study population. Those associated with allergic phenotypes are validated in large study populations. Relevant fingerprints are combined into network biomarker phenotype “handprints” using a systems biology approach and validated in a sufficiently powered sample. Animal studies and in vitro human immunology reinforce the validation. This information coupled with classical and novel phenotypes characterize environmental protective and susceptibility factors of allergy and risk groups. Results are fitted into new integrative complex mathematical models to establish suitable biomarkers for early diagnosis, prevention and targets for therapy of allergy-associated diseases such as asthma and atopic dermatitis. Ethics and gender are considered. MeDALL aims at improving health of European citizens, Europe competitiveness and innovative capacity while addressing global health issues.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2010-single-stage
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
75654 Paris
Francia
Ver en el mapa
Participantes (22)
08003 BARCELONA
Ver en el mapa
10117 Berlin
Ver en el mapa
75794 Paris
Ver en el mapa
9713 GZ Groningen
Ver en el mapa
9000 Gent
Ver en el mapa
00029 Helsinki
Ver en el mapa
90419 Lodz
Ver en el mapa
0313 Oslo
Ver en el mapa
1090 Wien
Ver en el mapa
7270 Davos Platz
Ver en el mapa
17177 Stockholm
Ver en el mapa
85764 Neuherberg
Ver en el mapa
3584 CS Utrecht
Ver en el mapa
75015 PARIS
Ver en el mapa
82152 STEINKIRCHEN
Ver en el mapa
08007 Barcelona
Ver en el mapa
1090 WIEN
Ver en el mapa
BD9 6RJ Bradford
Ver en el mapa
85281 Tempe
Ver en el mapa
1000 BRUXELLES
Ver en el mapa
5000 ODENSE
Ver en el mapa
00198 ROMA
Ver en el mapa